$ Value
$0
Shares
762,543
Price
$0
Filed
Sep 22
Insider
Name
Cowan Chad
Title
Chief Scientific Officer
CIK
0002039294
Roles
Transaction Details
Transaction Date
2025-09-18
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
992,489
Footnotes
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs vest 50% on October 1, 2026, with the remaining 50% vesting on October 1, 2027, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. | Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Filing Info
Cowan Chad's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | IPSC | F | $3K |
| 2026-03-11 | IPSC | F | $4K |
| 2026-02-02 | IPSC | A | $0 |
| 2026-02-02 | IPSC | A | $0 |
| 2026-01-02 | IPSC | F | $2K |
| 2025-12-22 | IPSC | ▲ | $49K ★ |
| 2025-11-20 | IPSC | ▼ | $3K |
| 2025-09-18 | IPSC | A | $0 |
Other Insiders at IPSC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Carr Douglas
SVP Finance & Operations
|
— | $19K | 2026-03-12 |
|
Russotti Gregory
See Remarks
|
— | $27K | 2026-03-12 |
|
Pfeiffenberger Brent
President and CEO
|
— | — | 2026-03-11 |
|
Cowan Chad
Chief Scientific Officer
|
— | — | 2026-04-01 |
| Murphy Martin Patrick | — | — | 2025-12-09 |